Mindfully Curated
Research teams have identified, for the first time, where special receptors are located on heart muscle cells. Their findings open up new perspectives for developing therapies for chronic heart failure.
A review of more than 9,000 US patients with severe COVID-19 infection showed less than 1 percent contracted the illness again, with an average reinfection time of 3.5 months after an initial positive test.
Plants evolve specialized defense chemicals through the combined effects of genes, geography, demography and environmental conditions.
Canadian researchers have discovered that a bee thought to be rarest in North America, as the only representative of its genus, is no more than an unusual specimen of a widespread species. They have reclassified the mystery bee, collected in Nevada in …
Changing your eating habits or altering your circadian clock can impact healthy fat tissue throughout your lifespan, according to a preclinical study.
Researchers used innovative imaging techniques to demonstrate symmetric collective alignment of nuclei in the muscle cells of the anterior midgut of the Drosophila embryo. This ‘collective nuclear behavior’ further influences bilateral asymmetry in the…
Inefficiency and poor positioning often go hand in hand.
Should you bet against Wall Street?
But peeking under the hood, the month-over-month comparisons aren’t so impressive.
One is a recent IPO, and the other can give investors international exposure.
A version rolling out next year will apparently contain a blood sugar monitor.
These shares aren’t for the faint of heart.
The company’s newly approved drug could generate billions in revenue per year.
Just how risky is cryptocurrency? It depends on your strategy.
These three Chinese companies are taking the electric scooter, e-commerce, and digital content market to new levels.
The tech company just isn’t a serious competitor, yet.
A value pick in the industrial sector.
These four companies are in the following high-growth markets: video streaming, e-commerce, cybersecurity, and audio streaming.
The science looks fishy for this small-cap biotech.
The controversy never ends with this biotech’s new Alzheimer’s drug.